Measurement Strategies for Evidence-Based Antidepressants for Posttraumatic Stress Disorder Delivery: Trends and Associations with Patient-Reported Outcomes.
Brian ShinerChristine LeonardJiang GuiSarah CorneliusJaimie L GradusPaula P SchnurrBradley V WattsPublished in: Administration and policy in mental health (2021)
We sought to develop a quality standard for the prescription of antidepressants for posttraumatic stress disorder (PTSD) that is both consistent with the underlying evidence supporting antidepressants as a treatment for PTSD and associated with the best levels of symptom improvement. We quantified antidepressant initiation during the first year of PTSD treatment in a 10-year national cohort of Department of Veterans Affairs (VA) users, and compared outcomes in a subgroup who completed patient-reported outcome measurement (PROM) as part of routine practice. We added progressively stringent measurement requirements. Prescribing quality for PTSD in the VA was stable over time. Use of PROM was rare in the case of antidepressant treatment, limiting our assessment of outcomes.
Keyphrases
- posttraumatic stress disorder
- patient reported outcomes
- major depressive disorder
- primary care
- social support
- emergency department
- randomized controlled trial
- type diabetes
- clinical trial
- adipose tissue
- bipolar disorder
- depressive symptoms
- insulin resistance
- skeletal muscle
- smoking cessation
- study protocol
- patient reported
- clinical evaluation